Alliance Wealth Advisors LLC UT Takes $1.26 Million Position in Synopsys, Inc. $SNPS

Alliance Wealth Advisors LLC UT bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,557 shares of the semiconductor company’s stock, valued at approximately $1,262,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management increased its stake in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. increased its position in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC purchased a new position in Synopsys during the third quarter worth approximately $27,000. SOA Wealth Advisors LLC. purchased a new position in Synopsys during the third quarter worth approximately $28,000. Finally, McIlrath & Eck LLC acquired a new position in shares of Synopsys in the 3rd quarter valued at $29,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Price Performance

SNPS stock opened at $439.94 on Friday. The firm has a market cap of $84.17 billion, a P/E ratio of 55.06, a price-to-earnings-growth ratio of 3.66 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a 50-day simple moving average of $474.06 and a 200-day simple moving average of $482.90.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the prior year, the business earned $3.40 EPS. Synopsys’s quarterly revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 4,157 shares of company stock valued at $1,945,036. Company insiders own 0.62% of the company’s stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on SNPS. KeyCorp increased their target price on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Piper Sandler lowered Synopsys from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $602.00 to $520.00 in a research note on Tuesday, January 13th. Morgan Stanley lifted their price objective on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, Needham & Company LLC raised their price target on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Nine analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $547.00.

View Our Latest Analysis on SNPS

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.